AUTOLOGOUS FIBRIN GLUE VERSES 4-0 SILK SUTURES IN PERIODONTAL FLAP CLOSURE

NCT03792113 | Unknown Phase 2 DMC

• 1 other identifier: nehafibringlue
• Study Type: interventional
• Target: 40
• Locations: 0 countries
• Sites: N/A

Brief Summary

The study is a split mouth study but the interventions for the two different arms will be spaced by a fixed duration in time. Verbal and written consent will be obtained from the patients fulfilling the inclusion and exclusion criteria after briefing them about the procedure. Following phase-1 periodontal therapy, randomisation for the test and control quadrants will be done. Surgical debridement will be done first for the control side to avoid the carry-across effect of fibrin glue. Control and test procedures will be performed with a wash out period of 15days. Preparation of Autologous fibrin glue :

• 10 ml of blood will be withdrawn from healthy adult human donor by venous puncture into sodium citrate vials and will be centrifuged for 30 min at 1200 g to obtain platelet-poor plasma (PPP).
• To the solution, fibrinogen and protamine sulphate will be added and will be centrifuged at 1000 g for 5 min to sediment the precipitate and fibrin glue will be procured. Prior to commencement of periodontal flap surgery GCF collection will be done. Following anaesthesia and elevation of full thickness muco periosteal flap, thorough debridement and root planning of the exposed root surfaces will be done. On the control site, the periodontal flap will be approximated using 4-0 black silk suture. Patients will be instructed to rinse twice daily with 0.12% chlorhexidine and recalled after 7 days for suture removal and post-surgical GCF collection from the control side. After a wash out period of 15 days presurgical GCF sampling along with the surgical procedure will be performed on the test side. The periodontal flap will be approximated on the test site using autologous fibrin glue on the under surface of the raised flap up to 2 mm from the coronal margin and repositioned back on to the root surface. Thereafter, the tissues will be kept in position with a gentle pressure using a wet gauze for 30 - 60 seconds. Persistence of bleeding, stability of tissues 5 minutes after repositioning will be recorded and the amount of fibrin sealant used in the procedure will be determined.Patients will be then recalled after 7 days for evaluation and post-surgical GCF collection from the test site. Clinical parameters will be assessed at 7, 14, 21 and 28 days. Collection of GCF : GCF will be collected immediately prior to surgery and on seventh day following surgery from both test and control sites for wound healing assessment. Samples of GCF will be collected from four sites from the surgical site following isolation. Colour - coded, 1-5 microlitre calibrated volumetric micro capillary pipettes will be kept extra-crevicularly for not more than five minutes or until 1 microlitre is collected. The fluid will be immediately transferred to a plastic vial and frozen at -20 degree Celsius for further analysis. Pipettes in sites which do not express any fluid or those contaminated with blood/saliva will be discarded. Statistical analysis: The data gathered from the study will be subjected to appropriate statistical analysis. The statistical analysis will be done using:
• Mann-Whitney test
• Wilcoxon signed rank test.

Conditions

Periodontitis

Outcome Measures

Primary Outcomes (1)

• Cytokine parameter

  Interleukin 1-β will be assessed in GCF using a commercially available Enzyme-linked immunosorbent assay kit (ELISA), specific for human IL-1 β

  Change from baseline to 7days

Secondary Outcomes (4)

• Oral Hygiene Index

  Changes from baseline to 7day, 14day, 21day, 28day

• Early Wound Healing Index

  Changes from baseline to 7th day, 14th day, 21st day and 28th day

• Gingival Index

  Changes from baseline to 7th day, 14th day, 21st day and 28th day

• VAS score

  Changes from baseline to 7th day, 14th day, 21st day and 28th day

Study Arms (2)

Autologous fibrin glue

EXPERIMENTAL

The periodontal flap will be approximated on the test site using autologous fibrin glue on the under surface of the raised flap up to 2 mm from the coronal margin and repositioned back on to the root surface. Thereafter, the tissues will be kept in position with a gentle pressure using a wet gauze for 30 - 60 seconds.

Procedure: Periodontal Flap Surgery; Other: Autologous fibrin glue

4-0 silk suture

ACTIVE COMPARATOR

The periodontal flap will be approximated using 4-0 black silk suture.

Procedure: Periodontal Flap Surgery; Other: 4-0 silk suture

Interventions

Periodontal Flap Surgery PROCEDURE

Periodontal access flap surgery will be performed in both test site followed by control site in each subject

4-0 silk suture; Autologous fibrin glue

Autologous fibrin glue OTHER

Autologous fibrin glue procured from the subject's own venous blood will be used to approximate periodontal flaps following access periodontal surgery

Autologous fibrin glue

4-0 silk suture OTHER

Conventional 4-0 black silk suture will be used to approximate periodontal flaps following access flap surgery

4-0 silk suture

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Patients diagnosed with periodontitis, with good systemic health and presence of a minimum of 3 teeth with periodontal pocket depth (PPD) of ≥6mm and clinical attachment level (CAL) of ≥5mm (stage 3 periodontitis as described by the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Condition and published by the American Academy of Periodontology) in at least two quadrants will be selected.

You may not qualify if:

• Patients who have undergone periodontal therapy during the previous 6 months, or exhibit poor plaque control after phase I therapy.
• History of any systemic disease such as diabetes mellitus, hypertension,osteoporosis, unstable or life-threatening conditions, bleeding disorder, undergoing antibiotic or other antimicrobial therapy.
• Patients on drugs like aspirin, blood thinners and anticoagulant therapy
• Patients with history of allergy
• Current or former smokers.
• Mobility of selected teeth.
• Pregnant or lactating women.

Sponsors & Collaborators

• KLE Society's Institute of Dental Sciences: lead

MeSH Terms

Conditions

Periodontitis

Condition Hierarchy (Ancestors)

Periodontal Diseases; Mouth Diseases; Stomatognathic Diseases

Central Study Contacts

Neha Pradhan, BDS, Post graduate student

CONTACT

9620508212; pradhanneha92@yahoo.in

Study Design

• Study Type: interventional
• Phase: phase 2
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: INVESTIGATOR, OUTCOMES ASSESSOR
• Masking Details: The study design follows a double blinded design where the investigator and the outcome assessor are unaware of the intervention to the subject
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Post graduate student, Principal investigator, Department of Periodontics, KLE Society's Institute of Dental Sciences, Bangalore

Model Details: Patients diagnosed with periodontitis, in the age group of 18 to 60 years with good systemic health and presence of a minimum of 3 teeth with periodontal pocket depth (PPD) of ≥6mm and clinical attachment level (CAL) of ≥5mm

Study Record Dates

• First Submitted: January 1, 2019
• First Posted: January 3, 2019
• Study Start: May 1, 2019
• Primary Completion: September 1, 2020
• Study Completion: December 1, 2020
• Last Updated: February 5, 2019

Record last verified: 2019-02

Data Sharing

• IPD Sharing: Will not share